Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cihan Ay

Showing results (201-210 of 344) with videos related to

Pageof 35
Sort By:
Journal of Thrombosis and Haemostasis : JTH|April 20, 2021
Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT)Johannes Thaler, Cihan Ay, Karoline V Gleixner, et al.
Journal of Thrombosis and Haemostasis : JTH|May 16, 2023
Growth differentiation factor-15 and prediction of cancer-associated thrombosis and mortality: a prospective cohort studyStephan Nopp, Florian Moik, Simon Kraler, et al.
Research and Practice in Thrombosis and Haemostasis|October 24, 2018
Management of anticoagulation for cancer-associated thrombosis in patients with thrombocytopenia: A systematic reviewBethany R Samuelson Bannow, Agnes Y Y Lee, Alok A Khorana, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2012
Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis StudyJonas Ahlbrecht, Boris Dickmann, Cihan Ay, et al.
International Journal of Molecular Sciences|February 25, 2023
Circulatory miR-411-5p as a Novel Prognostic Biomarker for Major Adverse Cardiovascular Events in Patients with Atrial FibrillationStephan Nopp, M Leontien van der Bent, Daniel Kraemmer, et al.
Research and Practice in Thrombosis and Haemostasis|April 4, 2024
Noninterventional study assessing joint health in persons with hemophilia A after switching to turoctocog alfa pegol: design of pathfinderRealCihan Ay, Olga Benitez-Hidalgo, Gillian Gidley, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 2, 2021
Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic CancerFlorian Moik, Gerald Prager, Johannes Thaler, et al.
Journal of Thrombosis and Haemostasis : JTH|October 11, 2024
Disappearance of antiphospholipid antibodies after anti-CD19 chimeric antigen receptor T-cell therapy of B-cell lymphoma in a patient with systemic lupus erythematosus and antiphospholipid syndromeEleonora Friedberg, Philipp Wohlfarth, Ana Iris Schiefer, et al.
British Journal of Haematology|April 11, 2019
Citrullinated histone H3, a biomarker for neutrophil extracellular trap formation, predicts the risk of mortality in patients with cancerElla Grilz, Lisa-Marie Mauracher, Florian Posch, et al.
Research and Practice in Thrombosis and Haemostasis|July 12, 2019
The role of ADAMTS-13 and von Willebrand factor in cancer patients: Results from the Vienna Cancer and Thrombosis StudyHanna L Obermeier, Julia Riedl, Cihan Ay, et al.
Pageof 35

Showing results (201-210 of 344) with videos related to

Sort By:
Pageof 35
Journal of Thrombosis and Haemostasis : JTH|April 20, 2021
Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT)Johannes Thaler, Cihan Ay, Karoline V Gleixner, et al.
Journal of Thrombosis and Haemostasis : JTH|May 16, 2023
Growth differentiation factor-15 and prediction of cancer-associated thrombosis and mortality: a prospective cohort studyStephan Nopp, Florian Moik, Simon Kraler, et al.
Research and Practice in Thrombosis and Haemostasis|October 24, 2018
Management of anticoagulation for cancer-associated thrombosis in patients with thrombocytopenia: A systematic reviewBethany R Samuelson Bannow, Agnes Y Y Lee, Alok A Khorana, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2012
Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis StudyJonas Ahlbrecht, Boris Dickmann, Cihan Ay, et al.
International Journal of Molecular Sciences|February 25, 2023
Circulatory miR-411-5p as a Novel Prognostic Biomarker for Major Adverse Cardiovascular Events in Patients with Atrial FibrillationStephan Nopp, M Leontien van der Bent, Daniel Kraemmer, et al.
Research and Practice in Thrombosis and Haemostasis|April 4, 2024
Noninterventional study assessing joint health in persons with hemophilia A after switching to turoctocog alfa pegol: design of pathfinderRealCihan Ay, Olga Benitez-Hidalgo, Gillian Gidley, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 2, 2021
Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic CancerFlorian Moik, Gerald Prager, Johannes Thaler, et al.
Journal of Thrombosis and Haemostasis : JTH|October 11, 2024
Disappearance of antiphospholipid antibodies after anti-CD19 chimeric antigen receptor T-cell therapy of B-cell lymphoma in a patient with systemic lupus erythematosus and antiphospholipid syndromeEleonora Friedberg, Philipp Wohlfarth, Ana Iris Schiefer, et al.
British Journal of Haematology|April 11, 2019
Citrullinated histone H3, a biomarker for neutrophil extracellular trap formation, predicts the risk of mortality in patients with cancerElla Grilz, Lisa-Marie Mauracher, Florian Posch, et al.
Research and Practice in Thrombosis and Haemostasis|July 12, 2019
The role of ADAMTS-13 and von Willebrand factor in cancer patients: Results from the Vienna Cancer and Thrombosis StudyHanna L Obermeier, Julia Riedl, Cihan Ay, et al.
Pageof 35